Approval · Notice of Compliance 23590 · 2020
GD-ELETRIPTAN: Notice of Compliance 23590
Issued May 13, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23590
- Date
- May 13, 2020
- Company
- Upjohn Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in product ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GD-ELETRIPTAN | 02342235 | Marketed |
| GD-ELETRIPTAN | 02342243 | Marketed |